Travere Therapeutics (TVTX) Revenue Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.82% |
| Dec 31, 2025 | -54.84% |
| Sep 30, 2025 | -4.79% |
| Jun 30, 2025 | 18.77% |
| Mar 31, 2025 | 11.34% |
| Dec 31, 2024 | 9.88% |
| Sep 30, 2024 | 7.23% |
| Jun 30, 2024 | 3.89% |
| Mar 31, 2024 | 0.90% |
| Dec 31, 2023 | 0.58% |
| Sep 30, 2023 | -1.84% |
| Jun 30, 2023 | -4.88% |
| Mar 31, 2023 | -4.28% |
| Dec 31, 2022 | -7.00% |
| Sep 30, 2022 | -6.99% |
| Jun 30, 2022 | -5.90% |
| Mar 31, 2022 | -6.98% |
| Dec 31, 2021 | -44.22% |
| Sep 30, 2021 | 10.13% |
| Jun 30, 2021 | 10.39% |
| Mar 31, 2021 | 10.32% |
| Dec 31, 2020 | 10.86% |
| Sep 30, 2020 | 12.80% |
| Jun 30, 2020 | 15.01% |
| Mar 31, 2020 | 22.42% |
| Dec 31, 2019 | 27.08% |
| Sep 30, 2019 | 39.67% |
| Jun 30, 2019 | 50.75% |
| Mar 31, 2019 | 326.62% |